RPMI 1640 medium without l-glutamine, l-cysteine, l-cystine and l-methionine was used as the base medium for different medium conditions (MP Biomedicals, 1646454)
L-Carnitina
Blood collection and analysis During the week before initiation of the experimental protocol and 12 weeks after the initiation, fasting blood samples were taken from the antecubital vein into BD Vacutainer tubes (Becton, Dickinson and Company, Franklin Lakes, NJ, USA)
In overweight or obese patients without diabetes mellitus, patients treated with GLP-1 RAs had significantly reduced major adverse cardiovascular events, all-cause death, myocardial infarction, and revascularization when compared with placebo [36] [37] [38]
Comparison Table: GLP-1 Injections vs GLP-1 Supplements and Patches What Is Lemme
Review: The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications